// App-Quantinova.ai

: The impact of Symkevi (Tezacaftor/Ivacaftor) on exercise capacity in adolescents with CF

Researchers

Presenter

  • Molla Imaduddin Ahmed

Principal Investigators

  • Naomi Dayman

  • Joe Madge

  • Erol Gaillard

Medical Centers

  • University of Leicester, Leicester, Leicestershire, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tezacaftor/ivacaftor

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved